MONEYWEB
app instead?
Longer gap between Pfizer doses boosts antibodies, study finds
‘This latest study provides further evidence that this interval results in a strong immune response and supports our decision,’ UK Vaccines Minister Nadhim Zahawi said.
By Janice Kew, Bloomberg
23 Jul 2021 06:20
Image: Bloomberg
An interval of eight to 10 weeks between doses of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE boosts the effectiveness of the two-shot regimen compared with a shorter interval, a UK study found.
âEight weeks is probably the sweet spot,â in terms of the trade-off between getting as many people fully vaccinated as quickly as possible and allowing the population to produce higher antibody levels, professor Susanna Dunachie, the study lead from the University of Oxford, said at a briefing Thursday.
Covid in Scotland: Children at higher risk of Covid to be vaccinated
bbc.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bbc.co.uk Daily Mail and Mail on Sunday newspapers.
UK shares Covishield data with EU, PM Johnson very confident of approval
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.